Status:

NOT_YET_RECRUITING

Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Thoracic Neoplasms

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Lung resection, a critical treatment for various thoracic diseases, including lung cancer, often necessitates prolonged hospitalization due to rare but severe postoperative complications such as chyle...

Detailed Description

This study is a single-center, prospective, randomized trial designed to investigate how a post-operative diet enriched with MCT affects recovery in patients undergoing video-assisted thoracic surgery...

Eligibility Criteria

Inclusion

  • General Inclusion Criteria for All procedures:
  • Age between 18 - 80 years
  • Body mass index \<35 kg/m2
  • Suitable for minimally invasive surgery
  • Willingness to participate as demonstrated by giving informed consent
  • Project-specific Criteria:
  • 1\. Patients performed lobectomy with lymph node dissection

Exclusion

  • Patient general exclusion criteria:
  • Contraindication to general anesthesia
  • Severe concomitant illness that drastically shortens life expectancy or increases the risk of therapeutic intervention
  • Untreated active infection
  • Non-correctable coagulopathy
  • Emergency surgery
  • Vulnerable population (e.g. mentally disabled, pregnancy)
  • Project-specific Criteria
  • Segmentectomy
  • Pleurodesis
  • Esophageal procedures
  • Redo/readmitted patients for lung resection
  • Chylothorax (Triglyceride \> 110 mL, excluded at day 1 routine lab check)
  • Air leak (\> 30 mL/min when back to ward)
  • Heart Failure
  • Renal failure (estimated GFR \< 30; CKD grading stage 4-5)
  • Moderate to severe adhesion (defined at randomization by surgeon; criteria include estimated surface area of adhesion and staging)
  • History of tuberculosis or empyema

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 30 2027

Estimated Enrollment :

210 Patients enrolled

Trial Details

Trial ID

NCT07159659

Start Date

September 1 2025

End Date

August 30 2027

Last Update

September 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Prince of Wales Hospital

Shatin, Hong Kong